Image

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Recruiting
18 years and older
Male
Phase N/A

Powered by AI

Overview

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Description

This trial will be comprised of prostate cancer patients who have undergone a radical prostatectomy and benign prostate hyperplasia patients who have undergone a laser enucleation of the prostate. These two cohorts will each be split into an intervention and a control group. The purpose of this study is to evaluate post-prostatectomy incontinence via patient reported outcomes utilizing Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises + standard of care (intervention group) compared to those receiving standard of care only (control group).

Eligibility

Inclusion Criteria:

  1. Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
  2. Patient of URMC Urology
  3. Adult male 18 years of age and older
  4. Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
  5. Has access to a mobile device capable of receiving automated text messages.
  6. Willing to receive text messages and to complete questionnaires via SMS text.
  7. Willingness to participate and able to provide informed consent.

Exclusion Criteria:

  1. Less than 18 years of age
  2. Unable to send and receive SMS texts
  3. Unable to read, write, and speak English
  4. Catheter dependency
  5. Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
  6. In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.

Study details
    Incontinence
    Urinary Stress
    Prostate Cancer
    Benign Prostate Hyperplasia

NCT07071207

University of Rochester

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.